Trial record 1 of 1 for:
LEveraging Methylated DNA Markers in the Detection of Endometrial Cancer
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer (ECHO)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05051722 |
|
Recruitment Status :
Recruiting
First Posted : September 21, 2021
Last Update Posted : May 16, 2024
|
Sponsor:
Mayo Clinic
Information provided by (Responsible Party):
Jamie N. Bakkum-Gamez, Mayo Clinic
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 30, 2025 |
| Estimated Study Completion Date : | December 30, 2025 |